Happy 2018, U.S. corporations! Now that you are beginning to revel in your giant tax cuts, please allow me to suggest some ways in which you can thank those of us (and our descendants, and their descendants) who are paying for your good fortune.
First, you can be aboveboard, ethical and moral in all of your business dealings. No more profits at the expense of safety; no more underhanded dealings with politicians; no more skimming and falsifying. If we could believe you were honorable institutions, we might feel a little better about supporting a government that is supporting you foremost.
Second, please open your workplaces without reservation and compensate your workers equally, especially protecting women and people of color by providing living-wage salaries, benefits (including health care and sick days) and an employee share in the profits. If we worked for you and felt good about it, we might be more inclined to smile when told that we must pay for you to get richer.
Third, please make sure your corporation is respectful of the environment in all of its dealings. After all, we wouldn't need federal regulations if companies were accountable for their impact and their actions. We could feel more positive about you if we thought you were interested not only in making money, barrel over barrel, but also in contributing to saving our planet for us and for future generations. I could go on, but you get the idea.
Again, congratulations on your huge windfall. Please thank us by using it justly and wisely. It's simple, and it's even good business practice: Please do the right thing.
Carol McNamara, Minneapolis
PRESIDENT DONALD TRUMP
Maybe the explanation lies in an affliction that hits many
I just spent an evening listening to reports legitimately questioning our president's mental competence and emotional stability. But the reporters are missing the crucial clinical question, i.e., whether these intellectual problems are characteristic of the man or represent a significant decline in functioning due to illness. There is a powerful case to be made that Donald Trump is, like President Ronald Reagan before him, serving while in the relatively early throes of a dementing illness such as Alzheimer's disease. It's an important question and one that we really should be trying to answer.
Kevin Turnquist, Shoreview
INMATES SUE FOR DRUG COSTS
Treat hepatitis C now to prevent a larger health, cost burden later
Regarding "Inmates sue to get costly drugs" (Jan. 2): Hepatitis C (HCV) is the most common bloodborne illness in the U.S. and the No. 1 cause for cirrhosis, liver cancer and liver transplant in our country. As health care providers specializing in the treatment of HCV, we understand the prohibitive effects of drug cost on the access to treatment. We have witnessed the negative impacts on individuals not allowed treatment and can foresee that an aging HCV population that is not aggressively treated now will only lead to an increased burden on our health care system at costs that far exceed any single HCV treatment.
Our prison populations are disproportionately infected with HCV. While it is true that in the past, regimens have cost up to or over $100,000, currently there is a regimen for less than $25,000 that works on all strains of HCV. At the current price, we are strongly advocating for treatment of all people infected with HCV who can successfully complete the course of medication.